Welcome to LookChem.com Sign In|Join Free

CAS

  • or

218456-76-9

Post Buying Request

218456-76-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

218456-76-9 Usage

Chemical compound

6-chloro-7-fluoro-2,3-diphenylquinoxaline

Class

Quinoxaline derivatives

Characterized by

Quinoxaline core with chlorine and fluorine substitutions at the 6 and 7 positions, two phenyl groups attached at positions 2 and 3

Biological activities

Antibacterial, antifungal, antiviral, anticancer

Potential applications

Medicinal and pharmaceutical research, treatment of neurological disorders, fluorescent probe in bioimaging techniques

Promising candidate for

Further research and development in drug discovery

Check Digit Verification of cas no

The CAS Registry Mumber 218456-76-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,8,4,5 and 6 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 218456-76:
(8*2)+(7*1)+(6*8)+(5*4)+(4*5)+(3*6)+(2*7)+(1*6)=149
149 % 10 = 9
So 218456-76-9 is a valid CAS Registry Number.

218456-76-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-chloro-7-fluoro-2,3-diphenylquinoxaline

1.2 Other means of identification

Product number -
Other names HMS662M12

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:218456-76-9 SDS

218456-76-9Downstream Products

218456-76-9Relevant articles and documents

Design, synthesis and anti-HIV activity of novel quinoxaline derivatives

Patel, Saloni B.,Patel, Bhumika D.,Pannecouque, Christophe,Bhatt, Hardik G.

, p. 230 - 240 (2016/04/26)

In order to design novel anti-HIV agents, pharmacophore modelling, virtual screening, 3D-QSAR and molecular docking studies were performed. Pharmacophore model was generated using 17 structurally diverse molecules using DISCOtech followed by refinement wi

Et3N-catalyzed oxidative dehydrogenative coupling of α-unsubstituted aldehydes and ketones with aryl diamines leading to quinoxalines using molecular oxygen as oxidant

Zhang, Chun,Xu, Zejun,Zhang, Liangren,Jiao, Ning

supporting information; experimental part, p. 5258 - 5262 (2012/08/08)

A novel Et3N-catalyzed oxidative dehydrogenative coupling of α-unsubstituted carbonyl compounds with aryl diamines leading to quinoxaline derivatives using molecular oxygen as oxidant has been developed. Six hydrogen dissociations involving 2 sp3 C-H bonds activation are realized under mild conditions in this approach. Plausible mechanism is proposed for this novel Et3N-catalyzed transformation on the basis of the aboratively designed mechanistic studies including the radical detection by EPR. 2012 Elsevier Science. All rights reserved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 218456-76-9